Addition of icosapent ethyl cuts CV risk in patients with prior PCI
The risk for cardiovascular events is reduced in statin-treated patients with elevated triglycerides and a history of percutaneous coronary intervention (PCI) who receive icosapent ethyl, according to a study published online ...
Mar 24, 2022
0
7